Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Peter F M Choong, Michelle M Dowsey, Derek Carr, John Daffy & Peter Stanley. (2007) Risk factors associated with acute hip prosthetic joint infections and outcome of treatment with a rifampinbased regimen. Acta Orthopaedica 78:6, pages 755-765.
Read now
Read now
David RP Guay. (2006) Moxifloxacin in the treatment of skin and skin structure infections. Therapeutics and Clinical Risk Management 2:4, pages 417-434.
Read now
Read now
Articles from other publishers (4)
Junchen Huang, Siwei Guo, Xin Li, Fang Yuan, You Li, Bing Xu, Junyuan Gu & Yong Qiao. (2022)
Nemonoxacin Enhances Antibacterial Activity and Anti-Resistance Mutation Ability of Vancomycin against Methicillin-Resistant Staphylococcus aureus in an
In Vitro
Dynamic Pharmacokinetic/Pharmacodynamic Model
. Antimicrobial Agents and Chemotherapy 66:2.
Crossref
Crossref
Jason C. Kwong, Kyra Chua & Patrick G. P. Charles. (2012) Managing Severe Community-Acquired Pneumonia Due to Community Methicillin-Resistant Staphylococcus aureus (MRSA). Current Infectious Disease Reports 14:3, pages 330-338.
Crossref
Crossref
Marco Cassone, Paraskevi Vogiatzi, Raffaele La Montagna, Vanessa De Olivier Inacio, Predrag Cudic, John D. Wade & Laszlo OtvosJr.Jr.. (2008) Scope and limitations of the designer proline-rich antibacterial peptide dimer, A3-APO, alone or in synergy with conventional antibiotics. Peptides 29:11, pages 1878-1886.
Crossref
Crossref
G.L. Pavoni, M. Giannella, M. Falcone, L. Scorzolini, M. Liberatore, B. Carlesimo, P. Serra & M. Venditti. (2004) Conservative medical therapy of prosthetic joint infections: retrospective analysis of an 8-year experience. Clinical Microbiology and Infection 10:9, pages 831-837.
Crossref
Crossref